Primary Sclerosing Cholangitis Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma
(Albany, New York) – October 26, 2026: As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies…